EClinCloud Product Overview | IRC · Independent Central Imaging Assessment Solution
Source: EClinCloud. Author: EClinCloud.
The EClinCloud IRC (Independent Review Committee) system uses advanced AI technology and platform capabilities to integrate image upload and image reading technologies, providing single-center and multicenter clinical trials with a standardized integrated independent review management platform that meets GxP requirements. Combining an IRC service team across multiple therapeutic areas (including oncology, central nervous system, and ophthalmology) with extensive expert reader resources, EClinCloud provides reliable endpoint solutions for clinical trials.

AI-Driven One-Stop Product + Service Solution
🔍 What Can EClinCloud Provide?
◉ IRC System
◉ System Configuration Services
◉ Independent Reader Management
◉ Independent Medical Imaging Review
◉ Independent Review Project Management
💡 Why Choose EClinCloud IRC?
❖ Experienced core team covering multiple indication areas
❖ Proprietary review system integrating image upload and reading platforms
❖ End-to-end medical team follow-up to ensure review timeliness and project quality
❖ Extensive senior specialist resources across multiple therapeutic areas for more specialized review services
❖ Review system and independent review service solutions across multiple therapeutic areas, including oncology and non-oncology (ophthalmology, central nervous system, dermatology, and pulmonology)
EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated clinical intelligence cloud platform and endpoint assessment technologies to provide global pharmaceutical companies and research institutions with technical products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services. It establishes efficient and accurate digital solutions and leverages AI predictive models and an intelligent data platform to dynamically evaluate and help improve the success rate of drug clinical trials, helping shorten drug and medical device R&D cycles for the benefit of patients.



